PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Glyceryl trinitrate 2mg MR buccal tab sugar free
0206010F0AAAKAK
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available
Glyceryl trinitrate 3mg MR buccal tab sugar free
0206010F0AAAMAM
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available
Glyceryl trinitrate 5mg MR buccal tab sugar free
0206010F0AAANAN
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available
Glyceryl trinitrate 5mg/5ml solution for infusion ampoules
0206010F0AAAUAU
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available
Glyceryl trinitrate 6.4mg modified-release tablets
0206010F0AAAPAP
Glyceryl trinitrate (Angina) Glyceryl trinitrate Cardiovascular System No data available
Glycophos 4.32g/20ml concentrate for inf vials
0905021S0BBAAAB
Glycophosphate (Phosphate) Sodium glycerophosphate Nutrition and Blood No data available
Glycopyrronium bromide 0.05% cream
1312000G0AAAYAY
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 0.2% in Aqueous cream
1312000G0AABDBD
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 0.5% in Aqueous cream
1312000G0AAAXAX
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 0.5% solution
1312000G0AAAIAI
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 1.25mg/5ml oral liquid
0102000L0AAALAL
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System No data available
Glycopyrronium bromide 1.3mg/5ml oral suspension
0102000L0AABJBJ
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System No data available
Glycopyrronium bromide 1.8mg/5ml oral liquid
0102000L0AAASAS
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System No data available
Glycopyrronium bromide 1% in Cetomacrogol cream (Formula A)
1312000G0AABABA
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 1% in Generic Unguentum M cream
1312000G0AABBBB
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 1% in White soft paraffin
1312000G0AABEBE
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 1% solution
1312000G0AAADAD
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 1% topical solution
1312000G0AABKBK
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 2% solution
1312000G0AAALAL
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 250micrograms/5ml oral liquid
0102000L0AAAQAQ
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System No data available
Glycopyrronium bromide 3% in Cetomacrogol cream (Formula A)
1312000G0AABHBH
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 300micrograms/5ml oral liquid
0102000L0AAAYAY
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System No data available
Glycopyrronium bromide 350micrograms/5ml oral liquid
0102000L0AAAMAM
Glycopyrronium bromide (Oral) Glycopyrronium bromide Gastro-Intestinal System No data available
Glycopyrronium bromide 4% in Cetomacrogol cream (Formula A)
1312000G0AABJBJ
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available
Glycopyrronium bromide 4% in Generic Unguentum M cream
1312000G0AABLBL
Glycopyrronium (Topical) Glycopyrronium bromide Skin No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.